Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

SHSE:603811 Stock Report

Market Cap: CN¥2.6b

Zhejiang Cheng Yi Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Zhejiang Cheng Yi Pharmaceutical has a total shareholder equity of CN¥1.2B and total debt of CN¥311.3M, which brings its debt-to-equity ratio to 24.9%. Its total assets and total liabilities are CN¥1.8B and CN¥569.2M respectively. Zhejiang Cheng Yi Pharmaceutical's EBIT is CN¥136.3M making its interest coverage ratio -4.2. It has cash and short-term investments of CN¥207.9M.

Key information

24.9%

Debt to equity ratio

CN¥311.30m

Debt

Interest coverage ratio-4.2x
CashCN¥207.91m
EquityCN¥1.25b
Total liabilitiesCN¥569.21m
Total assetsCN¥1.82b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 603811's short term assets (CN¥475.9M) exceed its short term liabilities (CN¥345.0M).

Long Term Liabilities: 603811's short term assets (CN¥475.9M) exceed its long term liabilities (CN¥224.2M).


Debt to Equity History and Analysis

Debt Level: 603811's net debt to equity ratio (8.3%) is considered satisfactory.

Reducing Debt: 603811's debt to equity ratio has increased from 0% to 24.9% over the past 5 years.

Debt Coverage: 603811's debt is well covered by operating cash flow (56.3%).

Interest Coverage: 603811 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies